Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Bioasis Technologies, Inc.
bioasis technologies, inc. is a biopharmaceutical company developing xb3, a proprietary platform technology for the delivery of therapeutics across the blood-brain barrier (bbb) and the treatment of cns disorders, including brain cancers and neurodegenerative diseases. the delivery of therapeutics across the bbb represents the final frontier in treating neurological disorders. the in-house development programs at bioasis are designed to develop effective treatments for patients suffering with neurological diseases. the goal of these programs is to produce symptomatic and disease-modifying treatments for brain-related diseases and disorders. bioasis continues to seek strategic relationships with leading biopharmaceutical partners and research institutions. the company has a unique collaborative phenotype that is a key ingredient to success that is lacking in many pharma companies today. our focus is to deliver hope to over 1.25 billion patients worldwide who suffer from hundreds of prev
Frequently asked questions about Bioasis Technologies, Inc.
Let us help answer the most common questions you might have.
Where is Bioasis Technologies, Inc. located?
Bioasis Technologies, Inc.'s headquarters is located at 14 Water Street, Guilford, Connecticut, United States, 06437
What is Bioasis Technologies, Inc.'s official website?
Bioasis Technologies, Inc.'s official website is bioasis.us
How many employees does Bioasis Technologies, Inc. have?
Bioasis Technologies, Inc. has 3 employees
What industry does Bioasis Technologies, Inc. belong to?
Bioasis Technologies, Inc. is in the industry of: Biotechnology
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free